Cost-effectiveness of Colorectal Cancer Screening in the Average Risk Population

Overview

Journal Health Care Manag Sci

Specialty Health Services

Date 2003 Aug 29

PMID 12943152

Citations 13

Authors

Moshe Leshno

Zamir Halpern

Nadir Arber

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is a leading cause of cancer death in North America and in Israel. Risk of CRC increases exponentially with age starting at the age of 50 years. Therefore, people older than 50 years are being considered as an average risk population for CRC. The objective of this study was to obtain an improved assessment of the cost-effectiveness analysis of screening for CRC in the average risk population by using a more accurate technique, namely the Partially Observed Markov Decision Process (POMDP). We conducted a cost-effectiveness analysis within the specific probability rates and costs in Israel. This study revealed that it is highly cost-effective to screen average-risk asymptomatic individuals.

Citing Articles

A two-phase approach to re-calibrating expensive computer simulation for sex-specific colorectal neoplasia development modeling.

Vivas-Valencia C, Zhou Y, Sai A, Imperiale T, Kong N BMC Med Inform Decis Mak. 2022; 22(1):244.

PMID: 36117168 PMC: 9482725. DOI: 10.1186/s12911-022-01991-7.

Does health economics research align with the disease burden in the Middle East and North Africa region? A systematic review of economic evaluation studies on public health interventions.

Nagi M, Rezq M, Sangroongruangsri S, Thavorncharoensap M, Dewi P Glob Health Res Policy. 2022; 7(1):25.

PMID: 35879742 PMC: 9309606. DOI: 10.1186/s41256-022-00258-y.

Using Sequential Decision Making to Improve Lung Cancer Screening Performance.

Petousis P, Winter A, Speier W, Aberle D, Hsu W, Bui A IEEE Access. 2020; 7:119403-119419.

PMID: 32754420 PMC: 7402617. DOI: 10.1109/ACCESS.2019.2935763.

Cost-effectiveness of colorectal cancer screening in Ukraine.

Melnitchouk N, Soeteman D, Davids J, Fields A, Cohen J, Noubary F Cost Eff Resour Alloc. 2018; 16:20.

PMID: 29977160 PMC: 5992826. DOI: 10.1186/s12962-018-0104-0.

Cost-Effectiveness Evaluation of EHR: Simulation of an Abdominal Aortic Aneurysm in the Emergency Department.

Ben-Assuli O, Ziv A, Sagi D, Ironi A, Leshno M J Med Syst. 2016; 40(6):141.

PMID: 27114352 DOI: 10.1007/s10916-016-0502-9.

References

Landis S, Murray T, Bolden S, Wingo P . Cancer statistics, 1998. CA Cancer J Clin. 1998; 48(1):6-29. DOI: 10.3322/canjclin.48.1.6. View

Stryker S, Wolff B, CULP C, Libbe S, Ilstrup D, MacCarty R . Natural history of untreated colonic polyps. Gastroenterology. 1987; 93(5):1009-13. DOI: 10.1016/0016-5085(87)90563-4. View

Dong S, Traverso G, JOHNSON C, Geng L, Favis R, Boynton K . Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst. 2001; 93(11):858-65. DOI: 10.1093/jnci/93.11.858. View

Sonnenberg A, Delco F, Inadomi J . Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000; 133(8):573-84. DOI: 10.7326/0003-4819-133-8-200010170-00007. View

Niv Y . Colorectal polyps in the Upper Galilee. Isr J Med Sci. 1989; 25(6):313-7. View

Eide T, Stalsberg H . Polyps of the large intestine in Northern Norway. Cancer. 1978; 42(6):2839-48. DOI: 10.1002/1097-0142(197812)42:6<2839::aid-cncr2820420645>3.0.co;2-y. View

Zarchy T, Ershoff D . Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy?. Gastroenterology. 1994; 106(6):1501-4. DOI: 10.1016/0016-5085(94)90403-0. View

Hofstad B, Vatn M, Larsen S, OSNES M . Growth of colorectal polyps: recovery and evaluation of unresected polyps of less than 10 mm, 1 year after detection. Scand J Gastroenterol. 1994; 29(7):640-5. DOI: 10.3109/00365529409092485. View

Neugut A, Jacobson J, Ahsan H, Santos J, Garbowski G, Forde K . Incidence and recurrence rates of colorectal adenomas: a prospective study. Gastroenterology. 1995; 108(2):402-8. DOI: 10.1016/0016-5085(95)90066-7. View

10.

Ness R, Holmes A, Klein R, Dittus R . Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol. 2000; 95(7):1800-11. DOI: 10.1111/j.1572-0241.2000.02172.x. View

11.

Krieger Y, Fraser D, Odes H, Krugliak P, FRASER G . [Screening for colorectal cancer and polyps]. Harefuah. 1992; 122(6):354-6, 408. View

12.

Jacobson J, Neugut A . Epidemiology of gastrointestinal polyps. Surg Oncol Clin N Am. 1996; 5(3):531-44. View

13.

Mandel J, Church T, Bond J, Ederer F, Geisser M, Mongin S . The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000; 343(22):1603-7. DOI: 10.1056/NEJM200011303432203. View

14.

Williams A, Balasooriya B, Day D . Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982; 23(10):835-42. PMC: 1419830. DOI: 10.1136/gut.23.10.835. View

15.

Neugut A, Jacobson J, De Vivo I . Epidemiology of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev. 1993; 2(2):159-76. View

16.

Lieberman D, Weiss D . One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001; 345(8):555-60. DOI: 10.1056/NEJMoa010328. View

17.

ALLISON J, Tekawa I, Ransom L, Adrain A . A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 1996; 334(3):155-9. DOI: 10.1056/NEJM199601183340304. View

18.

Winawer S, STEWART E, Zauber A, Bond J, Ansel H, Waye J . A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med. 2000; 342(24):1766-72. DOI: 10.1056/NEJM200006153422401. View

19.

Ahlquist D, Skoletsky J, Boynton K, Harrington J, Mahoney D, Pierceall W . Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology. 2000; 119(5):1219-27. DOI: 10.1053/gast.2000.19580. View

20.

Winawer S, Fletcher R, Miller L, Godlee F, Stolar M, Mulrow C . Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997; 112(2):594-642. DOI: 10.1053/gast.1997.v112.agast970594. View